Compagnie Lombard Odier SCmA’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,800	Closed	-$45K	–	660
2022 Q2	$45K	Hold	1,800	–	–	﹤0.01%	451
2022 Q1	$70K	Buy	+1,800	New	+$70K	﹤0.01%	411